These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The helical propensity of KLA amphipathic peptides enhances their binding to gel-state lipid membranes. Arouri A; Dathe M; Blume A Biophys Chem; 2013; 180-181():10-21. PubMed ID: 23792704 [TBL] [Abstract][Full Text] [Related]
3. Membrane interaction and perturbation mechanisms induced by two cationic cell penetrating peptides with distinct charge distribution. Alves ID; Goasdoué N; Correia I; Aubry S; Galanth C; Sagan S; Lavielle S; Chassaing G Biochim Biophys Acta; 2008; 1780(7-8):948-59. PubMed ID: 18498774 [TBL] [Abstract][Full Text] [Related]
4. Bladder tumor-targeted delivery of pro-apoptotic peptide for cancer therapy. Jung HK; Kim S; Park RW; Park JY; Kim IS; Lee B J Control Release; 2016 Aug; 235():259-267. PubMed ID: 27282414 [TBL] [Abstract][Full Text] [Related]
6. Chondroitin sulfate as a molecular portal that preferentially mediates the apoptotic killing of tumor cells by penetratin-directed mitochondria-disrupting peptides. Yang H; Liu S; Cai H; Wan L; Li S; Li Y; Cheng J; Lu X J Biol Chem; 2010 Aug; 285(33):25666-76. PubMed ID: 20484051 [TBL] [Abstract][Full Text] [Related]
7. Conjugation of a novel Apaf-1 inhibitor to peptide-based cell-membrane transporters: effective methods to improve inhibition of mitochondria-mediated apoptosis. Orzáez M; Mondragón L; Marzo I; Sanclimens G; Messeguer A; Pérez-Payá E; Vicent MJ Peptides; 2007 May; 28(5):958-68. PubMed ID: 17408805 [TBL] [Abstract][Full Text] [Related]
8. Coadministration of kla peptide with HPRP-A1 to enhance anticancer activity. Hao W; Hu C; Huang Y; Chen Y PLoS One; 2019; 14(11):e0223738. PubMed ID: 31703065 [TBL] [Abstract][Full Text] [Related]
9. Vesicles mimicking normal and cancer cell membranes exhibit differential responses to the cell-penetrating peptide Pep-1. Almarwani B; Phambu EN; Alexander C; Nguyen HAT; Phambu N; Sunda-Meya A Biochim Biophys Acta Biomembr; 2018 Jun; 1860(6):1394-1402. PubMed ID: 29621495 [TBL] [Abstract][Full Text] [Related]
10. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response. Jiang L; Li L; He X; Yi Q; He B; Cao J; Pan W; Gu Z Biomaterials; 2015 Jun; 52():126-39. PubMed ID: 25818419 [TBL] [Abstract][Full Text] [Related]
11. iRGD-targeted delivery of a pro-apoptotic peptide activated by cathepsin B inhibits tumor growth and metastasis in mice. Qifan W; Fen N; Ying X; Xinwei F; Jun D; Ge Z Tumour Biol; 2016 Aug; 37(8):10643-52. PubMed ID: 26867766 [TBL] [Abstract][Full Text] [Related]
12. Tumor-penetrating peptide fused to a pro-apoptotic peptide facilitates effective gastric cancer therapy. Huang Y; Li X; Sha H; Zhang L; Bian X; Han X; Liu B Oncol Rep; 2017 Apr; 37(4):2063-2070. PubMed ID: 28260064 [TBL] [Abstract][Full Text] [Related]
13. Two birds, one stone: dual targeting of the cancer cell surface and subcellular mitochondria by the galectin-3-binding peptide G3-C12. Sun W; Li L; Li LJ; Yang QQ; Zhang ZR; Huang Y Acta Pharmacol Sin; 2017 Jun; 38(6):806-822. PubMed ID: 28065935 [TBL] [Abstract][Full Text] [Related]
14. Lipid reorganization induced by membrane-active peptides probed using differential scanning calorimetry. Joanne P; Galanth C; Goasdoué N; Nicolas P; Sagan S; Lavielle S; Chassaing G; El Amri C; Alves ID Biochim Biophys Acta; 2009 Sep; 1788(9):1772-81. PubMed ID: 19427300 [TBL] [Abstract][Full Text] [Related]
15. An in-tether chiral center modulates the proapoptotic activity of the KLA peptide. Li J; Hu K; Chen H; Wu Y; Chen L; Yin F; Tian Y; Li Z Chem Commun (Camb); 2017 Sep; 53(75):10452-10455. PubMed ID: 28884757 [TBL] [Abstract][Full Text] [Related]
16. Apoptosis inducing, conformationally constrained, dimeric peptide analogs of KLA with submicromolar cell penetrating abilities. Hyun S; Lee S; Kim S; Jang S; Yu J; Lee Y Biomacromolecules; 2014 Oct; 15(10):3746-52. PubMed ID: 25188534 [TBL] [Abstract][Full Text] [Related]
17. Multivalent display of pendant pro-apoptotic peptides increases cytotoxic activity. Chu DS; Bocek MJ; Shi J; Ta A; Ngambenjawong C; Rostomily RC; Pun SH J Control Release; 2015 May; 205():155-61. PubMed ID: 25596326 [TBL] [Abstract][Full Text] [Related]
18. The enhanced membrane interaction and perturbation of a cell penetrating peptide in the presence of anionic lipids: toward an understanding of its selectivity for cancer cells. Jobin ML; Bonnafous P; Temsamani H; Dole F; Grélard A; Dufourc EJ; Alves ID Biochim Biophys Acta; 2013 Jun; 1828(6):1457-70. PubMed ID: 23462641 [TBL] [Abstract][Full Text] [Related]
19. A mitochondrial targeted fusion peptide exhibits remarkable cytotoxicity. Law B; Quinti L; Choi Y; Weissleder R; Tung CH Mol Cancer Ther; 2006 Aug; 5(8):1944-9. PubMed ID: 16928814 [TBL] [Abstract][Full Text] [Related]